Drug Trial Radar · NCT06208657
Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer
Last checked: Nov 19, 2026Latest source record: Jan 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
90
Planned (sponsor's estimate)
Start
Jul 10, 2024
Primary completion
Dec 2030
Study completion Dec 2035
Sponsor
- Lead sponsor
- Australian & New Zealand Children's Haematology/Oncology GroupAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- The Hospital for Sick Children; Medical Research Future Fund; Kazia Therapeutics Limited; C17 Council; Bristol-Myers Squibb; Stand Up To Cancer
- First posted
- Jan 17, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 0 years, up to 21 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A companion platform trial to test novel targeted agents based on the patient's tumor profile.
Conditions
- Childhood Cancer
- Childhood Solid Tumor
- Childhood Brain Tumor
- Recurrent Cancer
- Refractory Cancer
Interventions
PaxalisibDrug
Paxalisib starting at 21mg/m2 oral, daily, 28 day cycle, 13 cycles.
OpdualagDrug
Opdualag, a fixed-dose combination of Nivolumab 480mg and Relatlimab 160mg, intravenous, on day 1, 28 day cycle, 26 cycles
Irinotecan (drug)Drug
Irinotecan starting at 50mg/m2/day, intravenous, on days 1-5, 28 day cycle, 13 cycles.
Temozolomide (TMZ)Drug
Temozolomide starting at 150mg/m2/day, oral, on days 1-5, 28 day cycle, 13 cycles.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of participants treated with molecularly-targeted agents in each treatment arm.Time frame: 5 Years
- Recommended phase II dose for each treatment armTime frame: 3 Years
- Objective Response Rate (ORR) for each treatment arm.Time frame: 5 Years
Locations
14 sites in 2 countries. Site status is shown where the registry gives one.
John Hunter Children's Hospital
Newcastle, New South Wales, Australia · Recruiting
Sydney Children's Hospital, Randwick
Sydney, New South Wales, Australia · Recruiting
The Children's Hospital at Westmead
Sydney, New South Wales, Australia · Recruiting
Queensland Children's Hospital
Brisbane, Queensland, Australia · Recruiting
Women's and Children's Hospital
Adelaide, South Australia, Australia · Recruiting
Royal Hobart Hospital
Hobart, Tasmania, Australia · Recruiting
Monash Children's Hospital
Melbourne, Victoria, Australia · Recruiting
The Royal Children's Hospital
Melbourne, Victoria, Australia · Recruiting
Perth Children's Hospital
Perth, Western Australia, Australia · Recruiting
Stollery Children's Hospital
Edmonton, Canada · Not yet recruiting
CHU Sainte Justine
Montreal, Canada · Recruiting
Children's Hospital of Eastern Ontario
Ottawa, Canada · Not yet recruiting
The Hospital for Sick Children
Toronto, Canada · Recruiting
BC Children's Hospital
Vancouver, Canada · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.